Assignee
TEVA PHARMA
IL·400 granted patents·140 pending applications·7,397 citations·filing 1978–2023
Top patents by PatentIndex Score
540 records- 0197US8591463B1Re-useable injector device for syringeTEVA PHARMA·Filed 2013·Granted Nov 26, 2013·85 cites·18 claims
- 0297US7750051B2Crystalline solid rasagiline baseTEVA PHARMA·Filed 2007·Granted Jul 6, 2010·35 cites·14 claims
- 0397US7056942B2CarvedilolTEVA PHARMA·Filed 2004·Granted Jun 6, 2006·358 cites·5 claims
- 0497US6630514B2Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereofTEVA PHARMA·Filed 2001·Granted Oct 7, 2003·77 cites·36 claims
- 0597US6495721B1Sertraline hydrochloride Form II and methods for the preparation thereofTEVA PHARMA·Filed 2000·Granted Dec 17, 2002·58 cites·22 claims
- 0697US5877218ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Mar 2, 1999·153 cites·19 claims
- 0797US5532415AR-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereofTEVA PHARMA·Filed 1995·Granted Jul 2, 1996·169 cites·1 claims
- 0897US5519061AR-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereofTEVA PHARMA·Filed 1995·Granted May 21, 1996·139 cites·9 claims
- 0996US7855233B2Citrate salt of RasagilineTEVA PHARMA·Filed 2010·Granted Dec 21, 2010·34 cites·16 claims
- 1096US7619117B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2008·Granted Nov 17, 2009·39 cites·11 claims
- 1196US7495072B2Process for preparation of mixtures of polypeptides using purified hydrobromic acidTEVA PHARMA·Filed 2005·Granted Feb 24, 2009·51 cites·21 claims
- 1296US7195778B2Drug delivery system for zero order, zero order-biphasic, ascending or descending drug deliveryTEVA PHARMA·Filed 2002·Granted Mar 27, 2007·177 cites·44 claims
- 1396US6777552B2Processes for preparing calcium salt forms of statinsTEVA PHARMA·Filed 2002·Granted Aug 17, 2004·66 cites·41 claims
- 1496US5457133AR-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing themTEVA PHARMA·Filed 1994·Granted Oct 10, 1995·112 cites·14 claims
- 1596US5453446AUse of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease.TEVA PHARMA·Filed 1994·Granted Sep 26, 1995·104 cites·20 claims
- 1695US7923215B2Process for the measurement of the potency of glatiramer acetateTEVA PHARMA·Filed 2008·Granted Apr 12, 2011·32 cites·30 claims
- 1795US7547806B2Tannate salt of rasagilineTEVA PHARMA·Filed 2007·Granted Jun 16, 2009·44 cites·13 claims
- 1895US6528685B2Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1999·Granted Mar 4, 2003·47 cites·25 claims
- 1995US5914349ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Jun 22, 1999·50 cites·18 claims
- 2095US5891923AR-enantiomer of N-propargyl-1-aminoindan for the treatment of dementiaTEVA PHARMA·Filed 1995·Granted Apr 6, 1999·97 cites·10 claims
- 2195US5877221ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Mar 2, 1999·52 cites·29 claims
- 2295US5786390APharmaceutical compositions of the R-enantiomer of N-propargyl -1-aminoindanTEVA PHARMA·Filed 1995·Granted Jul 28, 1998·105 cites·19 claims
- 2395US5744500AUse of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereofTEVA PHARMA·Filed 1995·Granted Apr 28, 1998·100 cites·39 claims
- 2495US5668181AUse of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depressionTEVA PHARMA·Filed 1995·Granted Sep 16, 1997·92 cites·7 claims
- 2595US5639913AMethod for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1996·Granted Jun 17, 1997·63 cites·38 claims
- 2695US5576353AMethod of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compoundsTEVA PHARMA·Filed 1995·Granted Nov 19, 1996·101 cites·7 claims
- 2795US5466683AWater-soluble analogs of carbamazepineTEVA PHARMA·Filed 1994·Granted Nov 14, 1995·74 cites·17 claims
- 2895US5387612AUse of the R-enantiomers of N-propargyl-1-aminoindan compounds for treating Parkinson's diseaseTEVA PHARMA·Filed 1993·Granted Feb 7, 1995·114 cites·9 claims
- 2994US7687636B2Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparationTEVA PHARMA·Filed 2006·Granted Mar 30, 2010·11 cites·3 claims
- 3094US7598420B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2008·Granted Oct 6, 2009·46 cites·20 claims
- 3194US7589211B2Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparationTEVA PHARMA·Filed 2006·Granted Sep 15, 2009·10 cites·3 claims
- 3294US7582768B2Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparationTEVA PHARMA·Filed 2006·Granted Sep 1, 2009·11 cites·3 claims
- 3394US7572834B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2006·Granted Aug 11, 2009·49 cites·12 claims
- 3494US7435827B2Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparationTEVA PHARMA·Filed 2006·Granted Oct 14, 2008·11 cites·2 claims
- 3594US7151183B2Processes for preparing amorphous atorvastatin hemi-calciumTEVA PHARMA·Filed 2005·Granted Dec 19, 2006·11 cites·5 claims
- 3694US6881420B2Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferationTEVA PHARMA·Filed 2001·Granted Apr 19, 2005·58 cites·25 claims
- 3794US6696600B2L-DOPA ethyl ester salts and uses thereofTEVA PHARMA·Filed 2002·Granted Feb 24, 2004·42 cites·20 claims
- 3894US6306436B1Stabilized, acid-free formulation for sustained release of bupropion hydrochlorideTEVA PHARMA·Filed 2000·Granted Oct 23, 2001·136 cites·36 claims
- 3994US5994408ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Nov 30, 1999·54 cites·32 claims
- 4094US5599991AEsylate and sulfate salts of R(+)-N-propargyl-1-aminoindanTEVA PHARMA·Filed 1995·Granted Feb 4, 1997·84 cites·2 claims
- 4193USD827127SInjector penTEVA PHARMA·Filed 2016·Granted Aug 28, 2018·74 cites·1 claims
- 4293US7884208B2Crystals of laquinimod sodium, and process for the manufacture thereofTEVA PHARMA·Filed 2006·Granted Feb 8, 2011·27 cites·8 claims
- 4393US7429374B2Process for the measurement of the potency of glatiramer acetateTEVA PHARMA·Filed 2002·Granted Sep 30, 2008·41 cites·9 claims
- 4493US7250533B2Process for preparing Cinacalcet hydrochlorideTEVA PHARMA·Filed 2006·Granted Jul 31, 2007·25 cites·45 claims
- 4593US6528661B2Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxideTEVA PHARMA·Filed 2001·Granted Mar 4, 2003·64 cites·22 claims
- 4693US5880159ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Mar 9, 1999·47 cites·29 claims
- 4792US8652100B1Re-useable injector device for syringeTEVA PHARMA·Filed 2013·Granted Feb 18, 2014·41 cites·24 claims
- 4892US7973045B2Anhydrous form of dasatinib and process for preparation thereofTEVA PHARMA·Filed 2010·Granted Jul 5, 2011·35 cites·9 claims
- 4992US7491847B2Methods for isolating propargylated aminoindansTEVA PHARMA·Filed 2006·Granted Feb 17, 2009·55 cites·37 claims
- 5092US7446220B2Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acidTEVA PHARMA·Filed 2006·Granted Nov 4, 2008·9 cites·5 claims
Showing the top 50 of 540 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →